Biota

• About Biota
  • Our Business
  • Board of Directors & Senior Management
  • Scientific Advisory Board
  • Major Milestones
  • Corporate Governance
    • Summary of Code of Conduct
    • Summary of Continuous Disclosure Policy
    • Summary of Audit & Risk Committee
    • Summary of Remuneration & Nominations Committee
    • Summary of Share Trading Policy
    • Summary of Health & Safety Policy
• Research and Development
  • Influenza
  • Human rhinovirus
  • Respiratory syncytial virus
  • Hepatitis C virus
  • Hepatitis C non-nucleoside (HCV-NN)
  • Human cytomegalovirus
  • Multidrug resistant bacteria
• Products
  • Influenza Diagnostics
  • Relenza
  • Partnering Opportunities
• Investors
  • ASX Releases
  • Financial Reports & Key Dates
  • Share Price
  • Share Registry
  • Annual General Meetings
  • Analyst Reports
  • Media Materials
  • News & Articles
  • Scientific Publications & Presentations
• Contact Us